Onconetix (ONCO) Change in Cash (2021 - 2026)
Onconetix (ONCO) posted quarterly Change in Cash of -$1.5 million for Q1 2026, down 261.66% year-over-year from $930693.0 in Q1 2025, and down 134.32% quarter-over-quarter from $4.4 million in Q4 2025.
Onconetix (ONCO) Change in Cash (2021 - 2026) Analysis & Trends
Onconetix (ONCO) has reported Change in Cash for 6 consecutive years, with -$1.5 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Change in Cash fell 261.66% year-over-year to -$1.5 million; the TTM figure through Mar 2026 stood at $2.1 million (up 174.09% YoY), while the FY2025 annual figure was $4.6 million, up 217.05% from the prior year.
- Change in Cash fell to -$1.5 million in Q1 2026 per ONCO's latest filing, from $4.4 million in the prior quarter.
- Across five years, Change in Cash topped out at $16.7 million in Q1 2022 and bottomed at -$12.0 million in Q2 2023.
- Historically, Change in Cash has averaged $105152.9 across 5 years, with a median of -$589046.0 in 2024.
- Annual changes were most pronounced in 2022 — Change in Cash soared 6602.01% — and 2023, when it plunged 431.22%.
- Onconetix's Change in Cash stood at -$3.4 million in 2022, then rose by 8.4% to -$3.1 million in 2023, then soared by 109.84% to $305005.0 in 2024, then surged by 1337.39% to $4.4 million in 2025, then sank by 134.32% to -$1.5 million in 2026.
- Business Quant data shows ONCO's Change in Cash at -$1.5 million in Q1 2026, $4.4 million in Q4 2025, and $553041.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Cash (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 649.20 Mn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | -504.60 Mn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | -185.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 427.25 Mn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | -2.94 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | -2.83 Bn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | -37.42 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 225.59 Mn |
| 10 | Onconetix | 1.44 Mn | -4.50 Mn | 4,303.00 | 2.23 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 2.23 Mn |
| Mar 31, 2026 | -1.50 Mn |
| Dec 31, 2025 | 4.38 Mn |
| Sep 30, 2025 | 553,041.00 |
| Jun 30, 2025 | -1.29 Mn |
| Mar 31, 2025 | 930,693.00 |
| Dec 31, 2024 | 305,005.00 |
| Sep 30, 2024 | -589,046.00 |
| Jun 30, 2024 | -3.53 Mn |
| Mar 31, 2024 | -90,465.00 |
| Dec 31, 2023 | -3.10 Mn |
| Sep 30, 2023 | -1.57 Mn |
| Jun 30, 2023 | -12.03 Mn |
| Mar 31, 2023 | -4.50 Mn |
| Dec 31, 2022 | -3.38 Mn |
| Sep 30, 2022 | 6.89 Mn |
| Jun 30, 2022 | 3.63 Mn |
| Mar 31, 2022 | 16.68 Mn |
| Dec 31, 2021 | -813,541.00 |
| Sep 30, 2021 | -927,453.00 |